Home | Health News | Themes | Search | Blog | Testimonials | Blood Bank | About Us
 
   
   
   
   
   
   
   
 
testing

 
   
BACTIGEN  BIOGARACIN  EMUGENT DPS  G-MYCIN  G-MYCIN  G.MYCIN E/E  G20/80  GARAMAX  GARAMYCIN INJ  GARAMYCIN INJ  GARAMYCIN INJ  GENKA  GENKIND  GENSAT  GENSOL  GENSTER  GENTA SWIFT  GENTA SWIFT E/E  GENTACIP  GENTAM  GENTAMICIN  GENTAMICIN SULPHATE  GENTAMICIN-INJ  GENTAMYCIN  GENTAMYCIN INJ  GENTARIL  GENTASPORIN  GENTASPORIN E/E  GENTATE  GENTICYN  GENTICYN  GENTICYN EYE/EAR  GENTINA  GENTY  GEROCIN  GEROCIN DPS  INDOGENTA  INGEN  INTRAGEN  INTRAGEN E/E  KETAJET  LYRAMYCIN CREAM  LYRAMYCIN INJ  MYCIN  OPTOCIN  PROGEN EYE  TAMIACIN  ZENOTIC KIT  ZENTAX 
 



Indication & Dosage
 
 
Intramuscular
SEVERE INFECTIONS CAUSED BY SUSCEPTIBLE GM-VE ORGANISMS EG,
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
SEVERE INFECTIONS CAUSED BY SUSCEPTIBLE GM-VE ORGANISMS EG,
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
BILIARY TRACT INFECTIONS
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
BILIARY TRACT INFECTIONS
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
BRUCELLOSIS
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
BRUCELLOSIS
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
CAT SCRATCH DISEASE
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
CAT SCRATCH DISEASE
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
CYSTIC FIBROSIS
Adult: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
CYSTIC FIBROSIS
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
ENDOCARDITIS
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
ENDOCARDITIS
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
ENDOMETRITIS
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
ENDOMETRITIS
Child: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
GASTROENTERITIS
Adult: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
GASTROENTERITIS
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
GRANULOMA INGUINALE
Adult: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
GRANULOMA INGUINALE
Child: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
LISTERIOSIS
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
LISTERIOSIS
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
MENINGITIS
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
MENINGITIS
Child: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
OTITIS EXTERNA
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
OTITIS EXTERNA
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
PELVIC INFLAMMATORY DISEASE
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
PELVIC INFLAMMATORY DISEASE
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
PERITONITIS
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
PERITONITIS
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
PLAQUE
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
PLAQUE
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
PNEUMONIA
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
PNEUMONIA
Child: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
SEPTICAEMIA
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
SEPTICAEMIA
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
SKIN INFECTIONS
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
SKIN INFECTIONS
Child:  ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
UTI
Adult: As sulfate: 3-5 mg/kg/day, given in divided doses every 8 hr for 7-10 days.
 
Intramuscular
UTI
Child: ≤2 wk: 3 mg/kg every 12 hr; 2 wk-12 yr: 2 mg/kg every 8 hr.
 
Intramuscular
PROPHYLAXIS AND TREATMENT OF STREPTOCOCCAL AND ENTEROCOCCAL ENDOCARDITIS
Adult: As sulfate: 1 mg/kg every 8 hr, in combination with penicillin or vancomycin.
 
Intramuscular
SURGICAL PROPHYLAXIS
Adult: As sulfate: 120 mg before induction of anaesthesia, in combination with penicillin, vancomycin or teicoplanin .
 
Ophthalmic
SUPERFICIAL INFECTIONS OF THE EYE
Adult: As sulfate: Instil 1-2 drops of a 0.3% soln into the infected eye/s every 4 hr or up to 2 drops every hr in severe infections. Alternatively, apply a small amount of 0.3% oint bid-tid into the affected eye.
 
Topical/Cutaneous
BACTERIAL SKIN INFECTIONS
Adult: As a 0.1% cream; Apply to the affected area 3-4 times daily.
   
Precautions Concurrent use of neuromuscular blocking agents; myasthenia gravis, parkinsonism; conditions predisposing to ototoxicity and nephrotoxicity; lactation. Monitor plasma concentrations of gentamicin in patients receiving high doses or prolonged courses, in infants, elderly, patients with renal impairment, cystic fibrosis or significant obesity. Monitor auditory and renal functions.
   
Potentially Life-threatening 
Adverse Drug Reactions
Dizziness or vertigo; acute renal failure, interstitial nephritis, acute tubular necrosis; electrolyte imbalances; transient elevation of serum bilirubin and aminotransferases; purpura; nausea, vomiting; convulsions, mental depression, hallucinations. Atrophy or rat necrosis at inj sites.
   
Adverse Drug Reactions Nephrotoxicity, ototoxicity and neuromuscular blockade (may unmask or aggravate myasthaenia gravis).
   
Interactions Synergistic with ampicillin, benzylpenicillin and other β-lactam antibiotics. Increased risk of severe respiratory depression when used concurrently with anaesthetics or opioids. May reduce renal clearance of zalcitabine and induce hypocalcaemia when used with biphosphonates. Not to be used with agalsidase alfa or beta as it may inhibit α-galactosidase activity.
   
   
 

 

SocialTwist Tell-a-Friend
 
 
Home  |   Privacy Policy   |   News Lettter   |   Site Map   |  Disclaimer  |  About Us
   copyright@totalhealthneeds.com   Webmaster:- o3sa.co.in